- Home
- BZFDW vs GNLX Comparison
BZFDW vs GNLX Comparison
Compare BZFDW & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFDW
- GNLX
- Stock Information
- Founded
- BZFDW N/A
- GNLX 2001
- Country
- BZFDW United States
- GNLX United States
- Employees
- BZFDW 925
- GNLX N/A
- Industry
- BZFDW Movies/Entertainment
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- BZFDW Consumer Discretionary
- GNLX Health Care
- Exchange
- BZFDW Nasdaq
- GNLX Nasdaq
- Market Cap
- BZFDW N/A
- GNLX 103.6M
- IPO Year
- BZFDW 2021
- GNLX 2023
- Fundamental
- Price
- BZFDW $0.15
- GNLX $2.39
- Analyst Decision
- BZFDW
- GNLX Strong Buy
- Analyst Count
- BZFDW 0
- GNLX 4
- Target Price
- BZFDW N/A
- GNLX $18.25
- AVG Volume (30 Days)
- BZFDW N/A
- GNLX 116.5K
- Earning Date
- BZFDW N/A
- GNLX 11-14-2024
- Dividend Yield
- BZFDW N/A
- GNLX N/A
- EPS Growth
- BZFDW N/A
- GNLX N/A
- EPS
- BZFDW N/A
- GNLX N/A
- Revenue
- BZFDW N/A
- GNLX $8,000.00
- Revenue This Year
- BZFDW N/A
- GNLX N/A
- Revenue Next Year
- BZFDW N/A
- GNLX N/A
- P/E Ratio
- BZFDW N/A
- GNLX N/A
- Revenue Growth
- BZFDW N/A
- GNLX N/A
- 52 Week Low
- BZFDW N/A
- GNLX $1.60
- 52 Week High
- BZFDW N/A
- GNLX $16.36
- Technical
- Relative Strength Index (RSI)
- BZFDW N/A
- GNLX 44.83
- Support Level
- BZFDW N/A
- GNLX $2.13
- Resistance Level
- BZFDW N/A
- GNLX $2.53
- Average True Range (ATR)
- BZFDW 0.00
- GNLX 0.16
- MACD
- BZFDW 0.00
- GNLX 0.01
- Stochastic Oscillator
- BZFDW 0.00
- GNLX 39.55
About BZFDW BuzzFeed Inc. Warrant
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.